MMS Leadership

With more than 25 years of global experience in Information Technology (IT), enterprise business systems, and business processes, I am Chief Information Officer (CIO) at TrialAssure - The Ultimate Transparency Suite. I lead the strategic development of TrialAssure and I am responsible for overseeing the operational and strategic aspects of the company’s IT infrastructure, business process transformation, and process and application development. I work very closely with clients and service providers, spearheading key partnership initiatives with major technology providers.

Prior to TrialAssure, I held several leadership positions with global companies and led multiple large scale IT and business systems transformation initiatives. This includes establishing the governance over key enterprise business processes, as well as leading the formation of cloud strategy and architecture.

My expertise extends to ISMS areas, including quality certifications, and I am passionate about emerging technology needs within the pharmaceutical industry, including IT infrastructure requirements to support clinical trial transparency.

As Chief Scientific Officer at MMS - a global, leading clinical research organization - I provide oversight for all clinical activities especially submissions and complex regulatory projects. As needed by our sponsors, I lead advisory committee meetings and participate in advisory boards for drug development, as well as product defense strategies especially for critical safety issues and label strategy discussions.

Prior to MMS, I was a Clinical Lead at Parke-Davis and Pfizer, especially for LYRICA for Neuropathic pain and Fibromyalgia and led large global phase 3 programs, navigating clinical teams through two mergers, and strategically directing senior management through critical “Go” or “No Go” decisions at key stages in drug development.

With more than 20 years of experience in the pharmaceutical industry, I have been an invited speaker at several national and international events. Above all, I am dedicated to good science, strong process, continuous innovation and colleague engagement - one of our strategic corporate values.